Improving Treatment Predictions in Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow. About 30% of patients do not respond well to the first treatment. Current risk stratification systems such […]

Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow. About 30% of patients do not respond well to the first treatment. Current risk stratification systems such […]